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OBJECTIVES The goal of this study was to evaluate the incidence and effects of underdosage of injured
segments during intracoronary irradiation and to define the minimal length of safety margin
required to avoid mismatched source placement.
BACKGROUND Underdosage of injured segments due to misplacement of active source has been suggested as
the underlying mechanism for the occurrence of edge restenosis.
METHODS Baseline angiograms of 112 vessels in 109 patients with in-stent restenosis undergoing
coronary reintervention followed by intracoronary irradiation (192Ir: Checkmate, Cordis,
Miami, Florida; 32P: Gallileo, Guidant, Houston, Texas; 90Sr/Y: Beta-Cath, Novoste,
Norcross, Georgia) were analyzed. The distances between the outermost injury and outermost
end of “reference isodose length” (RIL), defined as a segment with 90% of reference dose
at 1 mm vessel wall depth, were measured. “Safety margin” was defined as the distance
between the outermost injury and outermost end of the RIL, “geographical miss” (GM) as a
complete injured segment not being covered by the RIL, and “restenosis” as the percent
diameter stenosis 50%.
RESULTS Baseline angiographic analysis was performed for 224 edges in 112 vessels. Geographical miss
was found in 46 (20.6%) edges. The incidence of target lesion restenosis within the 78 vessels
with available follow-up was 43.3% for patients with GM versus 14.9% for patients with no
GM (p  0.005). Analysis of various injured segments exposed highest restenosis rates in
injured segments with negligible irradiation (27.8%) in comparison with injured segments
with dose fall-off (16.7%) or injured segments with full-dose irradiation (7.7%) (p  0.006).
Receiver operating curve analysis revealed a safety margin of 10 mm required per vessel (i.e.,
5-mm safety margin/edge) to achieve 95% specificity of GM.
CONCLUSIONS Geographical miss is associated with a higher incidence of restenosis at the corresponding
edges. Restenosis was more pronounced in injured segments with negligible irradiation than
in injured segments at the dose fall-off zones. We recommend a safety margin of 10 mm per
vessel to minimize GM. (J Am Coll Cardiol 2002;40:1225–31) © 2002 by the American
College of Cardiology Foundation
Intracoronary irradiation with both beta and gamma sources
has previously been demonstrated to confer clinical benefit
in the treatment of in-stent restenosis (ISR) (1–3). How-
ever, intracoronary radiation therapy is still limited by the
occurrence of edge restenosis (4). Geographical miss (GM)
(i.e., irradiation underdosage within injured segments due to
mismatched placement of the active source) has been
suggested as the underlying mechanism (5,6). Besides other
factors such as mechanical difficulties in source placement,
GM may result from inadequate determination of the active
source length. Appropriate safety margins in the evaluation
of the active source length might reduce the incidence of GM;
however, required safety margin lengths have not been defined.
Recent studies have analyzed the effect of GM on
angiographic outcome at follow-up (7,8) and have suggested
GM as a potential factor for the occurrence of edge
restenosis. However, the precise mechanism involved in
edge restenosis is yet unknown, and so far, both neoin-
timal proliferation (9) and absence of positive remodeling
(10) have been implicated. Moreover, it is unclear if the
higher restenosis rate in the dose fall-off zone is caused by
an underdosage or absence of irradiation, similar to
conventional intervention, or rather by a stimulatory
effect of the combination of low-dose irradiation with
mechanical injury.
In this study we aimed to determine the incidence of GM
in patients with in-stent lesions undergoing beta or gamma
radiation treatment, to evaluate its impact on restenosis in
the dose fall-off zones in comparison with zones of negli-
gible irradiation and to define the minimal length of safety
margin required to minimize GM.
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METHODS
Patient population. Clinical, interventional, and baseline
angiographic data of 117 vessels undergoing coronary rein-
tervention of ISR with subsequent intracoronary irradiation
between September 1999 and July 2001 at the Department
of Cardiology, University of Vienna, were prospectively
selected and analyzed. Follow-up angiographic analysis of
78 vessels with available follow-up before November 2001
was performed. Ethics approval and written informed con-
sent according to the institutional guidelines for cardiac
catheterization and intracoronary irradiation were available
for all patients.
Coronary angiography and intervention. All patients un-
derwent routine biplane coronary angiography using the
Judkins technique. Before angiography 0.1 to 0.2 mg
intracoronary nitroglycerine was administered to achieve
maximal vasodilation. Baseline angiograms were recorded in
at least two projections on CD-ROM. Interventional treat-
ment of ISR included percutaneous transluminal balloon
angioplasty in 54 vessels (69.2%) and additional stent
deployment in 24 vessels (30.8%). All balloon inflations and
stent deployments were recorded.
According to the decision of the interventionist, intra-
coronary irradiation was performed using one of three
available systems (192Ir: Checkmate, Cordis, Miami, Flor-
ida; 32P: Gallileo, Guidant, Houston, Texas; 90Sr/Y: Beta-
Cath, Novoste, Norcross, Georgia). Dosimetry was per-
formed based on the reference diameter as determined by
intravascular ultrasound. Patients receiving 192Ir treatment
were irradiated with 13.5 Gy at 1 mm vessel depth, patients
receiving 32P treatment with 20 Gy, and patients receiving
90Sr/Y with 13.5 Gy at 1 mm vessel depth. After the
procedure patients were given aspirin (100 mg) for at least
one year and clopidogrel (75 mg) for at least six months.
Follow-up angiography was performed on a routine basis
after 6.9  2.3 months and was available for 78 vessels until
November 2001.
Definitions. Injury: intervention length. Reference isodose
length (RIL): segment receiving 90% of reference dose at
1 mm vessel wall depth. Safety margin: distance between
outermost injury and outermost end of RIL. Edge of
irradiation (dose fall-off segment): segment with 10% to 90%
of reference dose at 1 mm vessel wall depth. The length of
this segment was assumed 4.5, 2.0, and 2.5 mm proximal
and distal to the end of the active source for 192Ir, 32P, and
90Sr/Y treatment, respectively (11) (Fig. 1). Segment of
negligible irradiation: segment with 10% of reference dose
at 1mm vessel wall depth. This was taken as segment
outside the 4.5, 2.0, and 2.5 mm dose fall-off zone after the
end of the active source for 192Ir, 32P, and 90Sr/Y applica-
tion, respectively (11). No geographical miss: complete in-
jured segment covered by RIL. Geographical miss: complete
injured segment not covered by RIL. Target lesion: segment
affected by injury and/or irradiation.
Assumptions. Only the 32P system is capable of centering
the catheter within the vessel. However, in this analysis we
assumed all three sources to be centered in the lumen.
Further, based on experimental data, we assumed the vessel
diameter to have no significant impact on the length of the
dose fall-off zone and, consequently, on the RIL (11).
Angiographic analysis. A computer-assisted quantitative
coronary arteriographic edge-detection algorithm
(ACOMPC, Siemens, Erlangen, Germany) was used for
cineangiographic analysis. Both baseline and follow-up
angiographic analyses were performed in identical angio-
graphic projections by two experienced observers. Consen-
Abbreviations and Acronyms
%DS  percent diameter stenosis
GM  geographical miss
ISR  in-stent restenosis
MLD  minimal lumen diameter
RIL  reference isodose length
ROC  receiver operating curve
START  Stents and Radiation Therapy registry
Figure 1. Segmental distribution of radiation dose. (a) Segment of full-dose irradiation with 90% of reference dose at 1-mm vessel depth ( reference
isodose length [RIL]). (b) Segment between end of injury and end of RIL receiving full-dose radiation with 90% of reference dose at 1-mm vessel depth
( safety margin). (c) Segment of dose fall-off with 10% to 90% of reference dose at 1-mm vessel depth ( edge of irradiation). This segment was assumed
4.5, 2.0, and 2.5 mm proximal and distal to the end of the active source for 192Ir, 32P, and 90Sr/Y application, respectively (11). (d) Segment of negligible
irradiation with 10% of reference dose at 1 mm vessel depth.
1226 Syeda et al. JACC Vol. 40, No. 7, 2002
GM During Intracoronary Irradiation October 2, 2002:1225–31
sus between the two observers was reached in all cases.
Baseline and follow-up analyses were performed for proxi-
mal and distal edges.
Baseline analysis. Outermost proximal and outermost dis-
tal injuries were determined from end-diastolic frames
analyzing all film sequences with inflated balloons and
inflated stents in identical angiographic projections. The
length between the outermost injury and the outermost end
of the active source was calculated by subtracting the
distance between the pre-existing stent-ending and the
outermost end of injury from the distance between the
pre-existing stent-ending and the outermost end of the
active source. Based on experimental data, end of RIL at
each edge was assumed to be 4.5, 2.0, and 2.5 mm shorter
than the active source length for patients receiving 192Ir,
32P, and 90Sr/Y treatment, respectively (11). The safety
margin per edge was calculated as the difference between
outermost end of injury and outermost end of RIL (Fig. 1).
Because the pre-existing stent was used as a reference to
evaluate the safety margin, failure to locate its exact position
excluded the corresponding edge from further analysis.
Follow-up analysis. Follow-up angiographic analysis in-
cluded the assessment of minimal lumen diameter (MLD)
and percent diameter stenosis (%DS). Restenosis was de-
fined as %DS  50% and was assessed at the edges of
irradiation, within the sites of the pre-existing stents, in
non-injured irradiated segments in patients without GM,
and injured nonirradiated segments in patients with GM
(Figs. 2A and 2B). Further, because the median length of all
GMs of the 224 edges with baseline analysis was 4 mm,
MLD and %DS were equally assessed at the outermost 4
mm injured segments in patients with no GM (segments of
full-dose irradiation) (Fig. 2A), at the injured edges of
irradiation in patients with GM (segments of dose fall-off),
and at injured segments between end of dose fall-off zone
and outermost end of injury in patients with GM (segments
of negligible irradiation) (Fig. 2B). It should be noted that
the criteria of restenosis may be fulfilled in more than one
subsegment in the same vessel. Analysis was performed at
end-diastolic frames in order to minimize the variation
caused by cardiac motion and to maximize the contrast
filling of the coronary vessels.
Statistics. Data are expressed as frequencies or percentages
for discrete variables and means  SD for continuous
variables. Comparisons between groups were made using
the chi-square test for categorical variables and the Student
t test for continuous variables. Statistical significance was
considered present if p  0.05.
Sensitivity, specificity, and the cut-off value of safety
margin length as predictor of GM was established on the
basis of receiver operating characteristic (ROC) curves.
Receiver operating curve analysis was performed after ex-
Figure 2. Analyzed segments in patients with no geographical miss (GM) (A) and GM (B). (a) Injured segment with full-dose radiation. For comparison
with the median length of injured segments without full-dose irradiation in patients with GM (segment e in Fig. 2B), this segment was equally set to 4
mm. (b) Distance between end of injury and end of reference isodose length (full dose irradiation zone). (c) Edge of irradiation (dose fall-off zone). (d)
Distance between end of dose fall-off zone and outermost injury (negligible irradiation zone). (e) Length of GM.
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cluding all patients with GM resulting from mechanical
resistance while advancing the catheter.
RESULTS
Baseline data of total patient cohort. Baseline angio-
graphic analysis was performed for 117 vessels. Five vessels
could not be evaluated owing to poor quality of the
angiogram. Thus, final baseline analysis was available for
224 edges in a total of 112 vessels in 109 patients. Of these
112 vessels, 24 (21.5%) were treated with 192Ir, 37 (33.0%)
with 32P, and 51 (45.5%) with 90Sr/Y.
Geographical miss occurred at 46 of 224 (20.5%) edges in
42 of 112 (37.5%) vessels. Reasons for GM were additional
dilations owing to unsatisfactory angiographic results after
irradiation in 17 edges (37.0%), mechanical difficulties while
advancing the catheter in eight edges (17.4%), and unin-
tended mismatching between outermost injury and radia-
tion source in 21 edges (45.6%).
Detailed analysis of the incidence of GM with regard to
the different radiation sources is presented in Table 1. The
occurrence of GM was equally distributed among the three
radiation sources as well as between the proximal (24 of 112)
and distal (22 of 112) edges. In edges with GM, mean
length of inadequate source coverage was 5.7  5.7 mm
(median length, 4.2 mm). Mean safety margin within the
178 edges without GM was 7.5  5.2 mm (median length,
6.0 mm).
Figure 3 shows the sensitivity/specificity for each safety
margin length per vessel. Receiver operating curve analysis
revealed a cut-off value of 7.8-mm safety margin per vessel
(i.e., 3.9 mm for each edge) for the prediction of GM with
a sensitivity and specificity of 83.7%. The area under the
ROC curve is 0.92 (Fig. 4). In order to achieve 95%
specificity (true negative rate of GM), a safety margin length
of 10 mm is required per vessel (i.e., 5-mm safety margin for
each edge) (Fig. 3).
Baseline data of patients with available follow-
up. Angiographic follow-up was available for 78 vessels in
77 patients (192Ir: 17 vessels; 90Sr/Y: 33 vessels; 32P: 28
vessels) with a mean follow-up period of 6.9  2.3 months.
Follow-up analysis could not be performed in three distal
edges, because of total vessel occlusion proximal to the
corresponding edge. Thus, a total of 153 edges—78 proxi-
mal edges and 75 distal edges—were included in the
follow-up analysis.
In patients with available follow-up, GM occurred at 36
of 153 (23.5%) edges in 32 of 78 (41.0%) vessels. Mean
length of inadequate source coverage in edges with GM was
4.5  4.3 mm. Mean safety margin within the 117 edges
without GM was 7.2  5.0 mm.
Table 1. Incidence of GM Using the Different Radiation
Sources
Total Population (n  224 Edges)
192Ir (n  48) 32P (n  74) 90Sr/Y (n  102)
No GM 35 (72.9%) 64 (86.5%) 79 (77.5%)
(n  178 edges) (15 p/20 d) (32 p/32 d) (41 p/38 d)
GM 13 (27.1%) 10 (13.5%) 23 (22.5%)
(n  46 edges) (9 p/4 d) (5 p/5 d) (10 p/13 d)
Population With Available FUP (n  153 Edges)
192Ir (n  30) 32P (n  60) 90Sr/Y (n  63)
No GM 20 (66.6%) 51 (85.0%) 46 (73.0%)
(n  117 edges) (8 p/12 d) (26 p/25 d) (25 p/21 d)
GM 10 (33.3%) 9 (15.0%) 17 (27.0%)
(n  36 edges) (3 d/7 p) (5 D/4 p) (9 d/8 p)
d  distal edge; FUP  follow-up; GM  geographical miss; p  proximal edge.
Figure 3. Sensitivity and specificity curves for prediction of geographical
miss in relation to various safety margins per vessel. Determination of the
cut-off point with equal sensitivity and specificity (7.8 mm; 83.7%
sensitivity/specificity). In order to achieve 95% specificity, a safety margin
of 9.9 mm is required per vessel.
Figure 4. Receiver operating characteristic curve demonstrating the per-
formance of different safety margins for prediction of geographical miss.
Area under the curve: 0.92.
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Follow-up data. VESSEL ANALYSIS. Target vessel resteno-
sis was 30.8% in patients with available angiographic
follow-up and tended to be higher in patients with GM
(GM vs. no GM: 43.3% vs. 23.0%, p  0.05). The
incidence of restenosis within the entire length of the target
lesion was 25.7%, with a pronounced increase in the
presence of GM (GM vs. no GM: 43.3% vs. 14.9%, p 
0.005). Regarding ISR within the site of the pre-existing
stent, we found no higher incidence in patients with GM
(GM vs. no GM: 13.3% vs. 6.2%, p  NS). Accordingly,
the %DS within the site of the former lesion was similar in
both groups (GM vs. no GM: 21.1  27.7% vs. 15.4 
18.9%, p  NS).
EDGE ANALYSIS. The rate of restenosis at the edges of
irradiation was significantly higher in patients with GM
than in patients with no GM (GM vs. no GM: 16.7% vs.
4.3%, p  0.01) (Table 2). However, merely 5.6% exhibited
restenosis at the injured edges of irradiation only, without
extension into the zones of negligible irradiation, whereas
27.8% were found to have restenosis in injured segments of
negligible irradiation (p  0.01).
Table 3 compares angiographic follow-up data between
injured segments with negligible irradiation, injured seg-
ments with dose fall-off, and injured segments with full-
dose irradiation, demonstrating highest restenosis rates in
injured segments of negligible irradiation.
DISCUSSION
In this study we evaluated the incidence of GM during
intracoronary irradiation as an adjuvant treatment of ISR
and analyzed its impact on re-restenosis in different seg-
ments of the treated vessel. We found higher restenosis rates
at the edges of irradiation in patients with GM than in
patients with no GM, as well as increased restenosis rates in
injured segments with negligible irradiation compared with
injured segments of dose fall-off. Based on our data, we
developed a safety margin recommendation to minimize the
occurrence of GM.
Incidence of GM. Retrospective analysis of large-scale
trials has recently increased the general awareness of GM
during intracoronary irradiation as a potential predictor of
long-term restenosis (7,8). While Sianos et al. (7) describe
an incidence of 41.2% GM during beta irradiation in de
novo lesions, Kim et al. (8) report 34% GM during gamma
irradiation of in-stent lesions. Mismatched placement of the
radiation source may be explained by mechanical difficulties
due to complex vessel anatomy, technical limitations such as
short source lengths, lack of international definitions re-
garding the parameters for the assessment of safety margin
length, and the presence of a learning curve in the initial era
of intracoronary irradiation. Initially, the length of the
irradiation segment was kept short in order to avoid irradi-
ation of noninjured segments, thus increasing the risk of
GM. Hesitance in application of tandem treatment, because
of unknown consequences of overlapping irradiation, may
also have increased the incidence of GM. Today, interna-
tional recommendations for endovascular irradiation may be
used in treatment planning to determine the application
dose (12); however, definite safety margin lengths in order
to avoid GM have not been reported, and recommendations
given by the industry are not based on clinical data. Applied
to our definition of safety margin, the industrial recommen-
dations may be interpreted as a 2-mm margin at each edge
for the 32P-system and 2.5 mm at each edge for the 90Sr/Y
system (no definite recommendations available for the 192Ir
system). Our analysis revealed that a 10-mm safety margin
length per vessel is required to avoid GM in 95% of all
cases. The 10-mm safety margin recommendation is also
supported by data from the Stents and Radiation Therapy
(START) 40 registry, where the incidence of GM was
found to be lowered with the use of a longer source wire of
40 mm (GM: 7%) when compared with GM of the placebo
arm of the START trial with a shorter source wire of 30
mm (GM: 34%) (13). In fact, if we had always used a safety
margin 10 mm in all vessels in our patient cohort, GM
would theoretically have occurred in only three vessels
(2.7%). We point out from this analysis the importance of
Table 2. Incidence of Restenosis Within Different Analyzed
Segments at Follow-Up
No-GM
(n  117)
GM
(n  36) p Value
(A) Dose fall-off 5 (4.3%) 6 (16.7%) 0.01
(B) Outside target lesion 8 (6.8%) 0 NS
(C) Noninjured irradiated 5 (4.3%) NA —
(D) Injured nonirradiated NA 10 (27.8%) —
Analysis comprised the following segments: (A) dose fall-off zones in patients with
and without GM; (B) segments outside the target lesion in patients with and without
GM; (C) segments between outermost injury and outermost RIL in patients without
GM; (D) segments of negligible irradiation in patients with GM.
GM  geographical miss; NA  not applicable; RIL  reference isodose length.
Table 3. Angiographic Results at Follow-Up Comparing Various Injured Segments
(A) Segment of
Full-Dose Irradiation
(n  117)
(B) Segment of
Dose Fall-Off
(n  36)
(C) Segment of
Negligible Irradiation
(n  36) p Value
Restenosis 9 (7.7%) 6 (16.7%) 10 (27.8%) 0.006
%DS 21.1  19.7 28.7  16.5 38.7  23.4 0.001
MLD 2.0  0.7 1.8  0.6 1.4  0.7 0.003
(A) segments of full dose irradiation in patients with no GM; (B) segments of dose fall-off at edges of irradiation in patients
with GM; (C)  segments of negligible irradiation between end of dose fall-off zone and outermost injury in patients with GM;
GM  geographical miss; MLD  minimal lumen diameter; %DS  percent diameter stenosis.
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determining the active source length adequately, and we
suggest that a safety margin of at least 10 mm per vessel (i.e.,
5 mm per edge) be added to the injury length when
determining the RIL.
Impact on restenosis. Patients with ISR have an increased
incidence of neointimal hyperplasia after re-dilation, and
re-restenosis rates of up to 50% have been reported (14–16).
Catheter-based intracoronary irradiation as an adjunct
treatment was able to reduce the incidence of re-restenosis
to 20% to 30% (1,2). However, uncertainties remain regard-
ing the occurrence of intima hyperplasia at the edges of
irradiation. The phenomenon of candy-wrapper restenosis
has been previously described in the dose fall-off zones of
the beta-emitting radioactive stents (17). Furthermore,
recent studies have suggested catheter-based low-dose irra-
diation at edges of the active source in combination with the
presence of injury to be responsible for the recurrence of
edge restenosis (7,8). However, both of these studies con-
centrated their analysis on the edges of irradiation only and
did not include segments of GM with negligible irradiation.
Similar to these studies, our analysis also confirms a
higher incidence of restenosis (16.7%) in the dose fall-off
zones at the edges of the active source in the presence of
injury. However, only 5.6% of all patients with GM
exhibited the restenotic lesion at the site of the dose fall-off
zone only, without extension into segments of negligible
irradiation. In contrast, 27.8% of all patients with GM
experienced restenosis in injured segments of negligible
irradiation, and, in fact, the restenosis rates in these seg-
ments were comparable with those after conventional bal-
loon dilations without intracoronary irradiation (18,19).
Furthermore, direct comparison of injured segments with
negligible irradiation, injured segments with dose fall-off,
and injured segments receiving full-dose radiation revealed
the highest restenosis rates in segments with negligible
irradiation and only moderately increased restenosis rates in
segments of dose fall-off. So far, it is unknown if the higher
restenosis rates in the dose fall-off zone are caused by an
underdosage or missing irradiation similar to conventional
intervention, or rather by a stimulatory effect of the combi-
nation of low-dose irradiation with mechanical injury.
Whereas candy-wrapper restenosis appears to be the result
of neointimal hyperplasia in the 32P-emitting stents (20),
both neointimal proliferation (9) and the absence of positive
remodeling (10) have been suggested as possible explana-
tions for restenosis at the edges of irradiation in catheter-
based intracoronary irradiation. Nevertheless, our findings
show that restenosis rates at the injured dose fall-off zones
are still lower than those in injured segments with negligible
irradiation. In fact, in cases with no GM, there is no
significant difference between restenosis rates among the
non-injured zones of dose fall-off (4.3%) and the non-
injured zones of negligible irradiation (6.8%). In contrast, in
patients with GM, significant associations are found be-
tween dose application and the recurrence of restenosis
(16.7% restenosis in injured zones of dose fall-off vs. 27.8%
restenosis in injured zones of negligible irradiation).
Clinical implications. The present study demonstrates
that target lesion restenosis rates are markedly increased
from 15% to 43% in cases with GM during intracoronary
irradiation of ISR. Thus, even without GM, radiation
therapy cannot entirely eliminate intimal hyperplasia occur-
ring in in-stent lesions (9,21); however, appropriate irradi-
ation of the entire injured segment can drastically reduce the
incidence of target lesion restenosis. Based on our data, we
recommend that a 10-mm safety margin per vessel (i.e., 5
mm per edge) be added to the injury length when deter-
mining the RIL in order to minimize GM in daily routine
use.
Study limitations. This study included patients undergo-
ing either beta (90Sr/Y, 32P) or gamma (192Ir) irradiation
treatment, applying various radiation doses using three
different radiation sources. However, different radiation
sources with different dose applications best represent the
use of intracoronary irradiation in the clinical routine as an
adjunct treatment of ISR.
Injury was considered present in cases of balloon infla-
tions as recorded during angiography. However, injury may
have also been caused by guide wires, radiation catheters, or
balloon inflations mistakenly not recorded. Even the re-
moval of uninflated balloons may have caused vessel irrita-
tion.
Safety margin recommendations are based on retrospec-
tive data of our patient cohort. However, the analysis
included all consecutive irradiated in-stent lesions between
September 1999 and July 2001. Prospective validation of
our safety margin recommendation will be required to assess
its effect on the occurrence of GM and on long-term clinical
outcome. Further, the application of a 10-mm safety margin
will not necessarily prevent GM resulting from mechanical
difficulties in placement of the active source; however,
technical improvements such as the development of smaller-
sized radiation catheters will reduce this problem.
Conclusions. Geographic miss during intracoronary irra-
diation is strongly associated with the development of
restenosis at the corresponding edges. This restenosis pro-
cess is more pronounced in injured segments receiving
negligible irradiation than at the dose fall-off zones. We
recommend the inclusion of a safety margin of 10 mm per
vessel (i.e., 5 mm per edge) for the determination of the RIL
in order to minimize the occurrence of GM in clinical
applications.
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